- Global Pharma News & Resources

Press Releases - 2019-05-16

Date Title Company
16-May-2019 InnoVEX Returns in 2019 for New Thinking, New Engineering, and New Future Taipei Computer Association (TCA)
16-May-2019 MorphoSys AG: Primary Endpoint of L-MIND, a Combination Study of Tafasitamab (MOR208) and Lenalidomide, has been met, Confirming Previously Published Activity (news with additional features) MorphoSys AG
16-May-2019 MorphoSys AG: Ad hoc: Primary Endpoint of L-MIND, a Combination Study of Tafasitamab (MOR208) and Lenalidomide, has been met, Confirming Previously Published Activity MorphoSys AG
16-May-2019 Dr. Len Walt Joins CannTrust executive team as Chief Medical Officer CannTrust Holdings Inc.
16-May-2019 CEN Biotech Inc. announces a Merger Agreement with CSOC CEN BIOTECH INC.
16-May-2019 Annual General Meeting 2019 in Karo Pharma Aktiebolag Karo Pharma
16-May-2019 Lonza chooses Synpromics’ novel inducible promoter platform to manufacture biopharmaceuticals Synpromics
16-May-2019 Joint Educational Partnership to Train Physicians in Use of Endoscopic Ultrasound Will Launch at Digestive Disease Week Olympus Corporation of the Americas
16-May-2019 Tolero Pharmaceuticals to Highlight Clinical Data Evaluating Investigational Agent Alvocidib in Patients with Newly Diagnosed AML at EHA 2019 Tolero Pharmaceuticals, Inc.
16-May-2019 Global Flu Vaccine Market Forecast, Size, Strategies, Trends, Key Manufacturers and SWOT Analysis 2028 Wired Release
16-May-2019 Oncopeptides Announces Acceptance of Four Abstracts Highlighting Melflufen Clinical Programs for Presentation at 24th EHA Congress in June 2019 Oncopeptides AB
16-May-2019 Neurofeedback System Market Industry Outlines, Demand Analysis, Trends and Forecast Till 2028 Wired Release
16-May-2019 Global Pinaverium Bromide Market 2019 Size, Status And Precise Outlook 2028 Wired Release
16-May-2019 Pulmatrix Announces Leadership Change Pulmatrix, Inc.
16-May-2019 Worldwide Ophthalmology Amniotic Membrane Market Opportunities, Manufacture Size, Developments and Future Forecasts To 2028 Wired Release
16-May-2019 Cutting Edge Research from Integra Connect Will be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting Integra Connect
16-May-2019 Blueprint Medicines Announces Data Presentations at ASCO and EHA Meetings from Registration-Enabling Clinical Trials of Avapritinib and BLU-667 Across Multiple Patient Populations Blueprint Medicines Corporation
16-May-2019 Digipath Announces Results for the Fiscal Second Quarter 2019 Digipath, Inc.
16-May-2019 Akrevia Therapeutics Appoints Distinguished Research Leaders to Scientific Advisory Board Akrevia Therapeutics
16-May-2019 Adastra Pharmaceuticals Announces that Data from Phase 1b Clinical Trial of Zotiraciclib Will Be Presented at ASCO 2019 Adastra Pharmaceuticals, Inc.